Videos

Ron Lanton III, Esq, president, True North Political Solutions, LLC, explains how mobile health can affect specialty pharmacies.

Joel Wright, chief executive officer, Alliance Rx Walgreens Prime discusses how technology has influenced the way specialty pharmacists manage patient care.

A look at last week's top stories in the world of pharmacy.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

In this video from PainWeek 2017, Jeremy Adler, MS, PA-C, co-owner of Pacific Pain Medicine, discusses why opioid abuse has become an increasingly urgent issue.

In this video from PainWeek 2017, Jeremy Adler, MS, PA-C, co-owner of Pacific Pain Medicine, discusses the pharmacist's role in combating the opioid abuse epidemic.

A look at last week's top stories in the world of pharmacy.

A look at the top stories in pharmacy last week.

Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses the best strategies to ensure patient satisfaction.

In this video from PainWeek 2017, Hal Blatman, MD, medical director of Blatman Health and Wellness Center, discusses treatment options for sleep-related pain.

Bruce A. Feinberg, DO, vice president and chief medical officer of Cardinal Health Specialty Solutions, discusses the key elements of an effective cancer clinical care pathways program.

Insurers can also help address this devastating epidemic.

Advice from a pharmacist for patients who are dealing with nail fungus.

A look at the top stories in pharmacy last week.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Rina Shah, PharmD, Vice President, Pharmacy Operations and Specialty Pharmacy, Walgreens, talks about the importance of care coordination.

There are several roles pharmacists can play in managing patients with cardiovascular disease, including blood pressure and medication monitoring.

The rivaroxaban plus aspirin combination therapy to treat patients with stable coronary or peripheral artery disease showed such benefits in the COMPASS trial that it should become the standard of care.

John Rumsfeld, MD, PhD, chief innovation officer at the American College of Cardiology, discusses the vexing problem of patients who fail to fill or take recommended medications.

John Rumsfeld, MD, PhD, chief innovation officer at the American College of Cardiology, discusses the digital innovations that will have major effects on the cardiovascular field in years to come.

In this clip, Deepak Bhatt, MD, discusses how pharmacists should counsel patients taking aspirin and rivaroxaban, if approved.

In this clip, Steven Nissen, MD, of the Cleveland Clinic discusses some new data on anti-inflammatories and cardiovascular events that were presented this week at the European Society of Cardiology.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

A look at the top stories in pharmacy last week.

A look at last week's top stories in the world of pharmacy.

It is important to align pharmacy services with changes in the population.

Marcus H. Snow, MD, of the University of Nebraska Medical Center, discusses the importance of the treat-to target-strategy versus the non-targeted therapeutic approach in patients with rheumatoid arthritis.

Brandon Shank, PharmD, MPH, BCOP, discusses how pharmacists work with patients undergoing chemotherapy through transitions of care.